Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF SEPTEMBER 08, 2023 SAM #7955
MODIFICATION

66 -- Pertussis FHA and Pertussis Fimbriae Antibodies

Notice Date

9/6/2023 10:36:47 AM
 

Notice Type

Combined Synopsis/Solicitation
 

NAICS

325414 — Biological Product (except Diagnostic) Manufacturing
 

Contracting Office

CDC OFFICE OF ACQUISITION SERVICES ATLANTA GA 30333 USA
 

ZIP Code

30333
 

Solicitation Number

77861
 

Response Due

9/11/2023 9:00:00 AM
 

Archive Date

09/26/2023
 

Point of Contact

Kourtney Marshall, Phone: 4044984280
 

E-Mail Address

qrz9@cdc.gov
(qrz9@cdc.gov)
 

Description

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to BioRad Inc, to obtain Pertussis FHA and Pertussis Fimbriae Antibodies. The MPIR Immunobiology laboratory is working on assay development for the detection of Pertussis antigen. In order to create an antigen detection assay, monoclonal recombinant antibodies need to be obtained. This will be done by using bacterial toxin derived from Bordetella Pertussis and a cell surface protein of Bordetella Pertussis. These two monoclonal recombinant antibodies will be generated through means of HuCAL technology for the purpose of using these antibodies to perform in-vitro research studies. Pertussis FHA and Pertussis Fimbriae antibodies are needed to capture and detect the disease causing pertussis antigen. The Fimbriae monoclonal recombinant antibodies should recognize the bacterial toxin derived from Bordetella Pertussis, and the FHA monoclonal recombinant antibodies should recognize a cell surface protein of the Bordetella pertussis. As additional specification, the antibodies shall not recognize Closely Related Antigens or Cross-Reactive Antigens (CRAs). This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government.� A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.� Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.� Any quotation/response should be emailed to contract specialist at Qrz9@cdc.gov by 12:00pm 11 September, 2023.
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/2bc6d8b22ac34e68abbf01f5d231ebb1/view)
 

Place of Performance

Address: Atlanta, GA 30333, USA

Zip Code: 30333

Country: USA
 

Record

SN06819699-F 20230908/230906230102 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |